ReproCELL Inc.

ReproCELL Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY32.1
Market Cap
JPY16.17 B
Shares Outstanding
70.91 M
Public Float
66.71 M

Profile

Address
KDX Shin-Yokohama 381 Building, 9/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.reprocell.com
Updated 09/14/2018
ReproCELL Inc. engages in the development of diverse products with an underlying theme that focuses on stem cell technology. It operates through the following business divisions: Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells and Clinical Testing. The Induced Pluripotent Stem (iPS)/Embryonic Stem (ES) Cells division handles the manufacture and sale of research reagents, and the production and evaluation of cells.

Financials

View All

Chikafumi Yokoyama
President & Representative Director
Daisuke Usui
Chief Financial Officer, Director & IR Contact